Interstitial Cystitis Completed Phase 3 Trials for Omalizumab (DB00043)

Also known as: Cystitis, Interstitial / Interstitial Cystitides / Cystitis interstitial / Cystitis ulcerative

IndicationStatusPhase
DBCOND0028936 (Interstitial Cystitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01294878Omalizumab in Interstitial Cystitis/Bladder Pain SyndromeTreatment